NCT06946654 Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
| NCT ID | NCT06946654 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University People's Hospital |
| Condition | Elderly |
| Study Type | OBSERVATIONAL |
| Enrollment | 176 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 176 participants in total. It began in 2026-01-01 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This comprehensive, multidimensional evaluation assesses patient-related factors, disease-related factors, donor-related factors, and treatment-related factors. The study aims to identify potential risk factors influencing transplant outcomes in elderly patients and enhance the outcomes of allo-HSCT.
Eligibility Criteria
Inclusion Criteria: * (a)Age ≥55 years. * (b)Hematologic disorders with established indications for transplantation, including malignant and non-malignant hematologic diseases. (c)Willingness to provide informed consent. Exclusion Criteria: (a)Pregnancy. (b) Uncontrolled active infection. (c) Lack of informed consent. (d)Deemed ineligible for transplantation after investigator assessment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06946654 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06946654 currently recruiting?
Yes, NCT06946654 is actively recruiting participants. Contact the research team at sunyuqian83@hotmail.com for enrollment information.
Where is the NCT06946654 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06946654 clinical trial?
NCT06946654 is sponsored by Peking University People's Hospital. The trial plans to enroll 176 participants.